Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$460M |
| 2 |
Palo Alto Networks
PANW
|
+$363M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$330M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$291M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$755M |
| 2 |
Microsoft
MSFT
|
+$674M |
| 3 |
Apple
AAPL
|
+$642M |
| 4 |
Flutter Entertainment
FLUT
|
+$572M |
| 5 |
NVIDIA
NVDA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.47% |
| 4 | Healthcare | 4.72% |
| 5 | Communication Services | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $1.13M | ﹤0.01% |
+57,000
| New | +$1.3M |
|
|
3202
PUT
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $1.13M | ﹤0.01% |
+57,000
| New | +$1.3M |
|
3203
Bitwise Crypto Industry Innovators ETF
BITQ
$393M
| $1.13M | ﹤0.01% |
66,717
+36,465
| +121% | +$642K |
|
3204
Calumet Specialty Products
CLMT
$3.81B
| $1.13M | ﹤0.01% |
51,172
-18,701
| -27% | -$393K |
|
3205
Cogent Biosciences
COGT
$7.07B
| $1.13M | ﹤0.01% |
144,454
+76,038
| +111% | +$758K |
|
|
PRA
3206
DELISTED
ProAssurance
PRA
| $1.13M | ﹤0.01% |
70,775
+4,635
| +7% | +$73.7K |
|
3207
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
| $1.12M | ﹤0.01% |
12,778
-2,871
| -18% | -$248K |
|
3208
Global X FinTech ETF
FINX
$173M
| $1.12M | ﹤0.01% |
35,849
-180
| -0.5% | -$5.62K |
|
3209
Napco Security Technologies
NSSC
$1.3B
| $1.12M | ﹤0.01% |
31,452
+1,798
| +6% | +$69K |
|
3210
Frontline
FRO
$8.7B
| $1.12M | ﹤0.01% |
78,743
-1,496,427
| -95% | -$28M |
|
3211
InMode
INMD
$868M
| $1.12M | ﹤0.01% |
66,783
-6,736
| -9% | -$120K |
|
|
INN
3212
Summit Hotel Properties
INN
$748M
| $1.11M | ﹤0.01% |
162,638
+15,989
| +11% | +$105K |
|
3213
PRA Group
PRAA
$662M
| $1.11M | ﹤0.01% |
53,230
+2,768
| +5% | +$59.1K |
|
3214
Franklin FTSE India ETF
FLIN
$2.76B
| $1.11M | ﹤0.01% |
29,316
+1,787
| +6% | +$70.6K |
|
3215
Cannae Holdings
CNNE
$646M
| $1.11M | ﹤0.01% |
55,764
+5,537
| +11% | +$111K |
|
3216
Invesco S&P 500 Low Volatility ETF
SPLV
$7.13B
| $1.11M | ﹤0.01% |
15,815
-433,654
| -96% | -$31.3M |
|
3217
Dave Inc
DAVE
$4.8B
| $1.11M | ﹤0.01% |
12,736
+6,516
| +105% | +$437K |
|
|
GEAR
3218
DELISTED
Revelyst, Inc.
GEAR
| $1.1M | ﹤0.01% |
+57,320
| New | +$1.09M |
|
|
TPC
3219
Tutor Perini Cor
TPC
$4.38B
| $1.1M | ﹤0.01% |
45,514
+2,228
| +5% | +$60.5K |
|
3220
Castle Biosciences
CSTL
$813M
| $1.1M | ﹤0.01% |
41,327
+15,748
| +62% | +$480K |
|
3221
DHT Holdings
DHT
$2.99B
| $1.1M | ﹤0.01% |
118,553
+3,825
| +3% | +$39.3K |
|
|
DAWN
3222
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.1M | ﹤0.01% |
86,900
+27,000
| +45% | +$376K |
|
|
DAWN
3223
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.1M | ﹤0.01% |
86,900
+27,000
| +45% | +$376K |
|
3224
iShares MSCI Switzerland ETF
EWL
$2.21B
| $1.1M | ﹤0.01% |
23,935
+2,384
| +11% | +$116K |
|
3225
PUT
BridgeBio Pharma
BBIO
$16.1B
| $1.1M | ﹤0.01% |
+40,000
| New | +$1.03M |
|
Similar funds
Citigroup's Q4 2024 Portfolio in Review
As of Q4 2024, Citigroup held 6,077 positions worth $169B, down 2.4% from $173B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $7.85B in Q4 2024, closing 263 positions and reducing 1,533 holdings. Its most notable exit was Stericycle Inc, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Citigroup opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $19M.
- Citigroup's largest Q4 2024 buy was T-Rex 2X Long MSTR Daily Target ETF: 249,467 shares worth $19M.
- Citigroup added most to Jefferies Financial Group in Q4 2024, an estimated $460M increase.
- Citigroup's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $755M.
- Citigroup fully exited Stericycle Inc in Q4 2024, selling an estimated $125M.
- Citigroup's ten largest holdings make up 21% of its $169B portfolio in Q4 2024.
- Citigroup opened 429 new positions and closed 263 in Q4 2024.
- Citigroup's portfolio value fell 2.4% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.